Compare Hyperliquid Strategies Inc Common Stock (PURR) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hyperliquid Strategies Inc Common Stock vs Roivant Sciences Ltd. Common Shares — how do they compare? Hyperliquid Strategies Inc Common Stock trades at $11.31 (market cap $2.24B), while Roivant Sciences Ltd. Common Shares trades at $34.88 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 11× Hyperliquid Strategies Inc Common Stock's market cap, and Hyperliquid Strategies Inc Common Stock is more actively traded (14,135,020 versus 6,279,442). Which is the better fit depends on your goals — on Pluang, investors hold Hyperliquid Strategies Inc Common Stock for 0 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| PURR | ROIV | |
|---|---|---|
Market Cap | $2.24B | $24.72B |
Volume | 14,135,020 | 6,279,442 |
Sector | Financials | Health |
52-Week High | $14.09 | $41.81 |
52-Week Low | $3.10 | $16.04 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.10B | $20.99B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hyperliquid Strategies Inc Common Stock
Hyperliquid Strategies is a digital asset treasury company focused on managing a treasury of HYPE tokens, the native digital assets of the Hyperliquid Layer-1 blockchain.
Read more on PURR →About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →
